The oncoprotein ErbB3 is endocytosed in the absence of added ligand in a clathrin-dependent manner-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The oncoprotein ErbB3 is endocytosed in the absence of added ligand in a clathrin-dependent manner

Published:2012-03-20 Issue:5 Volume:33 Page:1031-1039
ISSN:1460-2180
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Sak Malgorzata Magdalena,Breen Kamilla,Rønning Sissel Beate,Pedersen Nina Marie,Bertelsen Vibeke,Stang Espen,Madshus Inger Helene

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/33/5/1031/17291592/bgs128.pdf

Reference62 articles.

1. ErbB receptor negative regulatory mechanisms: implications in cancer;Sweeney;J. Mammary Gland Biol. Neoplasia,2006

2. ErbB receptors and their ligands in the breast;Zahnow;Expert Rev. Mol. Med.,2006

3. Mechanisms for oncogenic activation of the epidermal growth factor receptor;Zandi;Cell. Signal.,2007

4. The ErbB signaling network: receptor heterodimerization in development and cancer;Olayioye;EMBO J.,2000

5. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization;Ferguson;Mol. Cell,2003

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting of PYK2 synergizes with EGFR antagonists in basal-like TNBC and circumvents HER3-associated resistance via the NEDD4–NDRG1 axis;Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies;2023

2. Control of phosphatidylinositol‐3‐kinase signaling by nanoscale membrane compartmentalization;BioEssays;2022-12-25

3. Ceritinib is a novel triple negative breast cancer therapeutic agent;Molecular Cancer;2022-06-29

4. Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer;Oncology Letters;2020-10-07

5. Regulation of the EGFR/ErbB signalling by clathrin in response to various ligands in hepatocellular carcinoma cell lines;Journal of Cellular and Molecular Medicine;2020-06-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3